Strong Revenue and Bookings Growth
Certara reported second quarter revenue of $104.6 million, representing 12% year-over-year growth. Second quarter bookings were $112 million, reflecting a 13% year-over-year increase.
Software Revenue Growth
Software revenue reached $46.7 million, increasing 22% over the prior year period. Simcyp, in particular, showed strong growth.
Significant Regulatory Milestone for Simcyp
Certara Simcyp received European Medicines Agency (EMA) qualification for a PBPK Modeling Platform, becoming the only software with this designation.
Introduction of CertaraIQ
Certara announced the upcoming release of CertaraIQ, an AI-enabled QSP software solution, signifying a major step in growing the market for QSP solutions.
Positive Impact of QSP Collaboration
Certara's QSP collaboration with IGI resulted in a clinical starting dose that reduced the need for animal testing and received a Fast Track designation for a new treatment.